Antibody-Mediated Rejection in Kidney Transplantation
A special issue of Antibodies (ISSN 2073-4468). This special issue belongs to the section "Humoral Immunity".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 96
Special Issue Editors
Interests: transplantation; biology; C1q; antibody-mediated rejection; risk analysis
Special Issue Information
Dear Colleagues,
Antibody-mediated rejection (AMR) represent a major challenge in kidney transplantation, affecting both the short- and long-term survival of grafts since it was discovered in the context of hyperacute rejection in the 1960s. The significant role that donor-specific antibodies (DSA) play in AMR, along with the deposition of the complement coponent C4d, was identified in the 1990s.
Although the advent of solid-phase assays and flow cytometry crossmatch has enabled the more precise detection of DSAs, challenges related to the development of optimal surveillance protocols for the early detection of subclinical AMR remain, as well as challenges regarding the elucidatation of the pathogenicity of non-HLA antibodies and anti-blood-type antibodies.
The treatments traditionally employed to remedy AMR include steroids, plasmapheresis, and intravenous immunoglobulin, later supplemented by B-cell depletion. Treatment options have expanded to include monoclonal antibodies targeting CD25, CD20 and C5. Additional approaches targeting other molecules in the immune system are also expected to emerge. Despite these advancements, chronic AMR remains a leading cause of late graft failure. Therefore, effective desensitization strategies or interventions are required to halt its insidious progression.
We welcome scientists and clinicians to contribute to this Special Issue of Antibodies, which aims to redefine the management of AMR in kidney transplantation and enhance the treatment of patients.
Dr. Kazuhiro Iwadoh
Prof. Dr. Hiroto Egawa
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibodies is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- AMR treatment
- anti-blood type antibodies
- antibody-mediated rejection (AMR)
- C4d deposition
- desensitization strategies
- donor-specific antibodies (DSA)
- kidney transplantation
- late graft failure
- non-HLA antibodies
- subclinical AMR detection
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
